Both in Pharmaceuticals
Crescent Biopharma vs CytomX Therapeutics
Over the past year CBIO returned +9.1% and CTMX returned −40.5%; their daily moves had a correlation of 0.28.
CBIO +9.1% CTMX −40.5%Growth of $1, one year, split-adjusted
| Metric | CBIO | CTMX |
|---|---|---|
| Price | $13.48 | $2.34 |
| Market cap | $500.7M | $509.9M |
| Today | −4.19% | +2.18% |
| 1 month | −5.5% | −11.0% |
| 6 months | −25.4% | −44.0% |
| Year to date | +13.7% | −45.1% |
| 1 year | +7.8% | −28.2% |
| Revenue growth (YoY) | — | −92.4% |
| Gross margin | — | 100.0% |
| Net margin | — | −1457.4% |
| P/E (TTM) | — | — |
| Price / sales | 42.1× | 27.9× |
| Net cash | $171.6M | $330.3M |
| Dividend yield | — | — |
| Volatility (60d) | 68.9% | 67.3% |
| Short % of float | 21.2% | 21.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).